Azab et al., 2023 (104), also made a case for meningiomas, describing MDSCs as tumor drivers and showing that infiltration by relevant T cells and PD1 and PD-L1 expression are reliable prognostic predictors, while discussing mutations that could provide neoantigens for infiltrating T cells. Here, CD274 is linked to meningioma.